Veeva Systems Inc. (VEEV)

NYSE · Pleasanton, California, USA · Founded 2007 · CEO Peter Gassner

Valuation summary

$159.16 fair value versus $262.92 in the market, a difference of -39.5%. Rated Sell.

Fair value per share$159.16
Current share price$262.92
Upside / downside-39.5%
Bear case$119.40
Bull case$214.93
Discount rate (WACC)9.9%
Terminal growth3.00%
Market capitalisation$43B
EV / Sales10.8x

About Veeva Systems Inc.

Founded in 2007 by Peter Gassner, previously at Salesforce, who still runs it. Veeva sells cloud software exclusively to life sciences companies — customer relationship management for pharmaceutical sales teams, plus clinical trial and regulatory document management. Building only for one heavily regulated industry means the software handles compliance requirements generic vendors do not attempt.

Investment case

  • Near-total focus on life sciences creates domain depth competitors cannot easily match.
  • Regulated document workflows have very high switching costs once validated.
  • Almost every large pharmaceutical company is already a customer, and they expand steadily.

Key risks

  • A relatively finite customer universe — there are only so many large drug companies.
  • Salesforce, its former platform partner, has become a direct competitor.
  • Pharmaceutical R&D budget pressure flows through to software spend.

Recent developments

Revenue by segment

Commercial Solutions45%
R&D Solutions55%

Five-year forecast

RevenueFree cash flow
Year 1$3.9B$0.7B
Year 2$4.6B$0.8B
Year 3$5.4B$0.9B
Year 4$6.2B$1.1B
Year 5$7.3B$1.3B

What the street says

Regarded as a high-quality vertical software business with a naturally bounded market. Fiscal second-quarter revenue rose 18% to $928 million, management raised its full-year outlook, and Vault CRM had what the CEO called its best quarter ever.

Comparable companies: TWLO · MDB · WDAY · EBAY · TEAM · ADSK · DASH · PINS

Open the interactive model, price chart and sensitivity grid →